In FY21, firm repaid $580-mn debt; board okays ₹2 dividendSun Pharmaceuticals Industries Ltd. reported fourth- quarter consolidated net profit jumped 124% from a year earlier to ₹894.1 crore. Adjusted net profit for the quarter was higher by 103.3% at ₹1,343 crore after excluding exceptional items, exceptional tax item and relevant minority interest, the company said in a filing. Consolidated sales from operations grew 4.4% to ₹8,431.4 crore. For FY21, the drugmaker reported a 23% decline in net profit to ₹2,903.8 crore. Consolidated sales from operations shrank 2.5% to ₹33,139.2 crore.

Source: The Hindu May 27, 2021 17:22 UTC